Dolby Laboratories (NYSE:DLB) Given Average Rating of “Moderate Buy” by Analysts

Dolby Laboratories (NYSE:DLBGet Free Report) has been given an average recommendation of “Moderate Buy” by the five research firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $90.75.

Several analysts have issued reports on DLB shares. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, January 30th. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, April 27th.

Read Our Latest Research Report on Dolby Laboratories

Dolby Laboratories Price Performance

Shares of DLB opened at $54.28 on Thursday. The firm has a market cap of $5.14 billion, a P/E ratio of 21.46 and a beta of 0.86. The stock has a 50 day simple moving average of $61.52 and a two-hundred day simple moving average of $63.94. Dolby Laboratories has a 1 year low of $53.45 and a 1 year high of $77.64.

Dolby Laboratories (NYSE:DLBGet Free Report) last issued its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. The business had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.Dolby Laboratories’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, equities analysts anticipate that Dolby Laboratories will post 3.22 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be given a $0.36 dividend. The ex-dividend date is Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.7%. Dolby Laboratories’s payout ratio is presently 56.92%.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total value of $198,420.00. Following the completion of the sale, the senior vice president owned 83,218 shares in the company, valued at approximately $5,504,038.52. The trade was a 3.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP John D. Couling sold 7,666 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the completion of the sale, the senior vice president owned 118,353 shares of the company’s stock, valued at $6,811,215.15. The trade was a 6.08% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 18,021 shares of company stock worth $1,090,741. 37.93% of the stock is currently owned by insiders.

Institutional Trading of Dolby Laboratories

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Sei Investments Co. lifted its position in Dolby Laboratories by 26.4% in the first quarter. Sei Investments Co. now owns 308,307 shares of the electronics maker’s stock valued at $18,516,000 after purchasing an additional 64,306 shares during the last quarter. Cetera Investment Advisers raised its holdings in shares of Dolby Laboratories by 50.1% during the first quarter. Cetera Investment Advisers now owns 8,681 shares of the electronics maker’s stock valued at $521,000 after acquiring an additional 2,898 shares in the last quarter. First Trust Advisors LP raised its holdings in shares of Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after acquiring an additional 374,405 shares in the last quarter. Johnson Financial Group Inc. raised its holdings in shares of Dolby Laboratories by 23.0% during the first quarter. Johnson Financial Group Inc. now owns 16,414 shares of the electronics maker’s stock valued at $986,000 after acquiring an additional 3,074 shares in the last quarter. Finally, Meeder Advisory Services Inc. bought a new position in shares of Dolby Laboratories during the first quarter valued at approximately $260,000. Institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Analyst Recommendations for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.